Retrieved from Barnett, M
Review the Omzo GLP-1 Program Structure, Pricing, and Refund Terms Before Enrolling Prescription medication is available only if a licensed clinician determines it is clinically appropriate
References include Jastreboff et al., New England Journal of Medicine , 2022 (SURMOUNT-1, tirzepatide for obesity), the FDA Zepbound prescribing information, the FDA Drug Shortages list (accessed Q1 2026), Patel et al., Annals of Pharmacotherapy , 2024 (compounded GLP-1 dosing errors), and the U.S
Both use identical active pharmaceutical ingredients prepared under licensed 503A pharmacy standards, ensuring potency and sterility comparable to branded products